Oa cartilage derived chondrocytes encapsulated in poly(ethylene glycol) diacrylate (PEGDA) for the evaluation of cartilage restoration and apoptosis in an in vitro model

Histology and Histopathology

Volumn 26, Issue 10, 2011, Pages 1265-1278

  Musumeci, Giuseppe ^a   Loreto, Carla ^a   Carnazza, Maria Luisa ^a   Strehin, Iossif ^b   Elisseeff, Jennifer ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Johns Hopkins University School of Medicine   (United States)

Author keywords

Apoptosis; Hydrogel; Immunohistochemistry; Osteoarthritis; TUNEL

Indexed keywords

MACROGOL DERIVATIVE; POLY(ETHYLENE GLYCOL)DIACRYLATE;

ADULT; AGED; APOPTOSIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL CULTURE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HYDROGEL; IMMUNOHISTOCHEMISTRY; KNEE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NICK END LABELING; OSTEOARTHRITIS; PATHOLOGY; PHYSIOLOGY; TISSUE ENGINEERING;

ADULT; AGED; APOPTOSIS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYDROGELS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS; POLYETHYLENE GLYCOLS; TISSUE ENGINEERING;

EID: 80053333636     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Aigner T., Soeder S. and Haag J. (2006). Il-1beta and bmps-interactive players of cartilage matrix degradation and regeneration. Eur. Cell. Mater. 12, 49-56.
2. Alenzi F.Q. (2005). Apoptosis and diseases: Regulation and clinical relevance. Saudi. Med. J. 26, 1679-1690.
3. Cavallo C., Desando G., Facchini A. and Grigolo B. (2009). Chondrocytes from patients with osteoarthritis express typical extracellular matrix molecules once grown onto a three-dimensional hyaluronan-based scaffold. J. Biomed. Mater. Res. A 93, 86-95.
4. Dehne T., Karlsson C., Ringe J., Sittinger M. and Lindahl A. (2009). Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation. Arthritis Res. Ther. 11(5):R133.
5. D'lima D.D., Hashimoto S., Chen P.C., Lotz M.K. and Colwell C.W. Jr (2001). Prevention of chondrocyte apoptosis. J. Bone. Joint. Surg. Am. 83, 25-26.
6. Elisseeff J., Mcintosh W., Anseth K., Riley S., Ragan P. and Langer R. (2000). Photoencapsulation of chondrocytes in poly(ethylene oxide)- based semi-interpenetrating networks. J. Biomed. Mater. Res. 51, 164-171.
7. Goldring M.B. (2006). Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best. Pract. Res. Clin. Rheumatol. 20, 1003-1025.
8. Goldring S.R. and Goldring M.B. (2004). The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat. Res. 427, 27-36.
9. Gutowska A., Jeong B. and Jasionowski M. (2001). Injectable gels for tissue engineering. Anat. Rec. 263, 342-349.
10. Hashimoto S., Takahashi K., Ochs R.L., Coutts R.D., Amiel D. and Lotz M. (1999). Nitric oxide production and apoptosis in cells of the meniscus during experimental osteoarthritis. Arthritis. Rheum. 42, 2123-2131.
11. Hashimoto M., Nakasa T., Hikata T. and Asahara H. (2008). Molecular network of cartilage homeostasis and osteoarthritis. Med. Res. Rev. 28, 464-481.
12. Hough A.J. Jr and Webber R.J. (1990). Pathology of the meniscus. Clin. Orthop. Relat. Res. 252, 32-40.
13. Hubbell J.A. (1995). Biomaterials in tissue engineering. Biotechnology. New York. pp 565-576.
14. Jeon S.I., Lee J.H, Andrade J.D. and de Gennes P.G. (1991). Protein-- surface interactions in the presence of polyethylene oxide: I. Simplified theory. J. Colloid Interface Sci. 142, 149-158.
15. Kim H.A., Lee Y.J., Seong S.C., Choe K.W. and Song Y.W. (2000). Apoptotic chondrocyte death in human osteoarthritis. J. Rheumatol. 27, 455-462.
16. Kuhn K., D'lima D.D., Hashimoto S. and Lotz M. (2004). Cell death in cartilage. Osteoarthritis Cartilage 12, 1-16.
17. Langer R. and Vacanti J.P. (2006). Tissue engineering. Science 260, 920-926.
18. Lorenz H. and Richter W. (2006) Osteoarthritis: Cellular and molecular changes in degenerating cartilage. Prog. Histochem. Cytochem. 40, 135-163.
19. Loreto C., Musumeci G. and Leonardi R. (2009). Chondrocyte-like apoptosis in temporomandibular joint disc internal derangement as a repair-limiting mechanism. An in vivo study. Histol. Histopathol. 24, 293-298.
20. Lutolf M.P. and Hubbell J.A. (2005). Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23, 47-55.
21. Majno G. and Joris I. (1995). Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146, 3-15.
22. Mapel D.W., Shainline M., Paez K. and Gunter M. (2004). Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain. J. Rheumatol. 31, 573-583.
23. Masuda K., Sah R.L., Hejna M.J. and Thonar E.J. (2003). A novel two- step method for the formation of tissue-engineered cartilage by mature bovine chondrocytes: The alginate-recovered-chondrocyte (arc) method. J. Orthop. Res. 21, 139-148.
24. Mauck R.L., Soltz M.A., Wang C.C., Wong D.D., Chao P.H., Valhmu W.B., Hung C.T. and Ateshian G.A. (2000). Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels. J. Biomech. Eng. 122, 252-260.
25. Musumeci G., Loreto C., Carnazza M.L. and Martinez G. (2011). Characterization of apoptosis in articular cartilage derived from the knee joints of patients with osteoarthritis. Knee. Surg. Sports. Traumatol. Arthrosc. 19, 307-313.
26. Peppas, N.A. (1987). Hydrogels in medicine and pharmacy. CRC Press. Boca Raton. pp 171.
27. Pooler A.R. (2001). Cartilage in health and disease. In: Arthritis and allied conditions: A textbook of rheumatology. Koopman W. (ed). Lippincott Williams & Wilkins. Philadelphia. pp 226-284.
28. Pritzker K.P., Gay S., Jimenez S.A., Ostergaard K., Pelletier J.P., Revell P.A., Salter D. and van den Berg W.B. (2006). Osteoarthritis cartilage histopathology: Grading and staging. Osteoarthritis Cartilage 14, 13-29.
29. Rosemann T., Laux G. and Szecsenyi J. (2007). Osteoarthritis: Quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patients. J. Orthop. Surg. Res. 2, 12.
30. Roy S. and Meachim G. (1968). Chondrocyte ultrastructure in adult human articular cartilage. Ann. Rheum. Dis. 27, 544-558.
31. Scott J.C., Lethbridge-Cejku M. and Hochberg M.C. (1999). Epidemiology and economic consequences of osteoarthritis. In: Osteoarthritis. Clinical and experimental aspects. Pelletier J.P., Martel-Pelletier J. and Henrotin Y. (eds). Springer. Berlin. pp 20-52.
32. Stoop R., Albrecht D., Gaissmaier C., Fritz J., Felka T., Rudert M. and Aicher W.K. (2007). Comparison of marker gene expression in chondrocytes from patients receiving autologous chondrocyte transplantation versus osteoarthritis patients. Arthritis Res. Ther. 9, R60
33. Terraciano V., Hwang N., Moroni L., Park H.B., Zhang Z., Mizrahi J., Seliktar D. and Elisseeff J. (2007). Differential response of adult and embryonic mesenchymal progenitor cells to mechanical compression in hydrogels. Stem Cells 25, 2730-2738.
34. Vacanti J.P. (1988). Beyond transplantation. Third annual samuel Jason mixter lecture. Arch. Surg. 123, 545-549.
35. Vacanti C.A. (2006). The history of tissue engineering. J. Cell. Mol. Med. 10, 569-576.
36. White E. (1996). Life, death, and the pursuit of apoptosis. Genes. Dev. 10, 1-15.
37. van der Sluijs J.A., Geesink R.G, van der Linden A.J., Bulstra S.K., Kuyer R. and Drukker J. (1992). The reliability of the Mankin score for osteoarthritis. J. Orthop. Res. 1992 10, 58-61.